Search research articles
Contact Us
Filters
Showing results (181-190 of 301) with videos related to
Page
of 31
Sort By:
The American Journal of Managed Care
|
September 15, 2009
Patient adherence: a blind spot in cost-effectiveness analyses?
Allison B Rosen, Alicen B Spaulding, Dan Greenberg, et al.
The American Journal of Managed Care
|
April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences
Pei-Jung Lin, David M Kent, Aaron Winn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models
Natalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
The Oncologist
|
May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S
Ashley A Leech, Peter J Neumann, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications
Peter J Neumann, Meghan I Podolsky, Anirban Basu, et al.
Pharmacoeconomics
|
July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study
Pei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Health Affairs (Project Hope)
|
November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower Costs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Policy (Amsterdam, Netherlands)
|
March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers
Josh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
BMC Nephrology
|
May 1, 2015
Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study
Keri L Monda, Parveen Nedra Joseph, Peter J Neumann, et al.
Applied Health Economics and Health Policy
|
November 25, 2021
Are Medical Devices Cost-Effective?
James D Chambers, Madison C Silver, Flora C Berklein, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 301) with videos related to
Sort By:
Page
of 31
The American Journal of Managed Care
|
September 15, 2009
Patient adherence: a blind spot in cost-effectiveness analyses?
Allison B Rosen, Alicen B Spaulding, Dan Greenberg, et al.
The American Journal of Managed Care
|
April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences
Pei-Jung Lin, David M Kent, Aaron Winn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models
Natalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
The Oncologist
|
May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S
Ashley A Leech, Peter J Neumann, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications
Peter J Neumann, Meghan I Podolsky, Anirban Basu, et al.
Pharmacoeconomics
|
July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study
Pei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Health Affairs (Project Hope)
|
November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower Costs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Policy (Amsterdam, Netherlands)
|
March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers
Josh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
BMC Nephrology
|
May 1, 2015
Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study
Keri L Monda, Parveen Nedra Joseph, Peter J Neumann, et al.
Applied Health Economics and Health Policy
|
November 25, 2021
Are Medical Devices Cost-Effective?
James D Chambers, Madison C Silver, Flora C Berklein, et al.
Page
of 31